150P Interim results of the multicenter phase II study on induction pembrolizumab plus chemotherapy followed by radiotherapy in locally advanced head and neck cancer
Conclusions: Toripalimab combined with chemotherapy is effective and well tolerated as first line treatment for patients with advanced thymic carcinoma.
Authors
- Evgenia Kuzmina (ORCID: https://orcid.org/0009-0007-2856-5176)
- Polina S. Feoktistova (ORCID: https://orcid.org/0000-0002-0340-7119)
- R. S. Sydykova (ORCID: https://orcid.org/0000-0002-5569-3655)
- В. Н. Галкин (ORCID: https://orcid.org/0000-0002-6619-6179)
- A. Tedeeva
- Maria Nosova (ORCID: https://orcid.org/0000-0001-7365-0301)
- Т. В. Антонова (ORCID: https://orcid.org/0000-0002-1784-6235)
- O. Stativko (ORCID: https://orcid.org/0009-0002-1084-1551)
- Antonina N. Fedorova
- Marina A. Lyadova (ORCID: https://orcid.org/0000-0002-9558-5579)
- Г.А. Ализаде
- И. А. Покатаев (ORCID: https://orcid.org/0000-0001-9864-3837)
- Е Т Сабитов (ORCID: https://orcid.org/0009-0009-5110-2457)
- Sergei Iugai (ORCID: https://orcid.org/0009-0000-9778-4208)
- Daniil Stroyakovskiy (ORCID: https://orcid.org/0000-0003-1973-1092)
- Lyudmila Zhukova (ORCID: https://orcid.org/0000-0003-4848-6938)
- Kristina N. Lisitsyna (ORCID: https://orcid.org/0009-0002-6817-4907)
- С А Кравцов (ORCID: https://orcid.org/0000-0002-0681-8976)
- E. Tsareva (ORCID: https://orcid.org/0009-0006-0637-9826)
- M. Dolov
Institutions
- International University in Moscow (RU)
- Moscow Clinical Scientific Center (RU)
- Mercy Medical Center (US)
- Moscow City Oncology Hospital №62 (RU)
Publication Details
- Journal
- Immuno-Oncology Technology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1016/j.iotech.2024.100779
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00